The anti‐tumor AAV‐mediated delivery of soluble extracellular domain of PD‐1 (sPD‐1) could reduce tumor microenvironment inhibitory effects on T cells and enhance cytotoxicity by lymphocytes stimulated specifically with an antigen [137]. Here, PDCD1 is linked to neoplasm.